http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107088199-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8964 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 |
| filingDate | 2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107088199-B |
| titleOfInvention | Alpha-glucosidase restrainer and its application |
| abstract | The invention discloses a kind of α glucosidase inhibitors, including：4 thio 2' BrdUs.The α glucosidase inhibitors are used to prepare the drug or prodrug of prevention type II diabetes.α glucosidase inhibitors provided by the invention can effectively inhibit the activity of α glucuroides, and then effectively reduce type II diabetes people's postprandial blood sugar content.The present invention also provides application α glucosidase inhibitors preparation for preventing the drug of type II diabetes, count in parts by weight, the drug includes：4 thio 5 10 parts of 2' BrdUs, the second 80 90 parts of active ingredient of Chinese herbs.Above-mentioned α glucosidase inhibitors provided by the invention carry out rational proportion with other second active ingredient of Chinese herbs and are prepared into effective blood sugar reducing health drug for preventing type II diabetes, after medication in 12 weeks, it is 42.7% to the cure-remarkable-effectiveness rate of patients with NIDDM, high efficiency is up to 95.2%. |
| priorityDate | 2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.